367 related articles for article (PubMed ID: 28212753)
1. The TRAIL-Induced Cancer Secretome Promotes a Tumor-Supportive Immune Microenvironment via CCR2.
Hartwig T; Montinaro A; von Karstedt S; Sevko A; Surinova S; Chakravarthy A; Taraborrelli L; Draber P; Lafont E; Arce Vargas F; El-Bahrawy MA; Quezada SA; Walczak H
Mol Cell; 2017 Feb; 65(4):730-742.e5. PubMed ID: 28212753
[TBL] [Abstract][Full Text] [Related]
2. Caspase-8 Acts in a Non-enzymatic Role as a Scaffold for Assembly of a Pro-inflammatory "FADDosome" Complex upon TRAIL Stimulation.
Henry CM; Martin SJ
Mol Cell; 2017 Feb; 65(4):715-729.e5. PubMed ID: 28212752
[TBL] [Abstract][Full Text] [Related]
3. Macrophage and cancer cell cross-talk via CCR2 and CX3CR1 is a fundamental mechanism driving lung cancer.
Schmall A; Al-Tamari HM; Herold S; Kampschulte M; Weigert A; Wietelmann A; Vipotnik N; Grimminger F; Seeger W; Pullamsetti SS; Savai R
Am J Respir Crit Care Med; 2015 Feb; 191(4):437-47. PubMed ID: 25536148
[TBL] [Abstract][Full Text] [Related]
4. The adaptor protein FADD and the initiator caspase-8 mediate activation of NF-κB by TRAIL.
Grunert M; Gottschalk K; Kapahnke J; Gündisch S; Kieser A; Jeremias I
Cell Death Dis; 2012 Oct; 3(10):e414. PubMed ID: 23096115
[TBL] [Abstract][Full Text] [Related]
5. ER stress regulates myeloid-derived suppressor cell fate through TRAIL-R-mediated apoptosis.
Condamine T; Kumar V; Ramachandran IR; Youn JI; Celis E; Finnberg N; El-Deiry WS; Winograd R; Vonderheide RH; English NR; Knight SC; Yagita H; McCaffrey JC; Antonia S; Hockstein N; Witt R; Masters G; Bauer T; Gabrilovich DI
J Clin Invest; 2014 Jun; 124(6):2626-39. PubMed ID: 24789911
[TBL] [Abstract][Full Text] [Related]
6. N-Acetyl-Glucosamine Sensitizes Non-Small Cell Lung Cancer Cells to TRAIL-Induced Apoptosis by Activating Death Receptor 5.
Liang Y; Xu W; Liu S; Chi J; Zhang J; Sui A; Wang L; Liang Z; Li D; Chen Y; Niu H
Cell Physiol Biochem; 2018; 45(5):2054-2070. PubMed ID: 29533936
[TBL] [Abstract][Full Text] [Related]
7. Receptor-mediated endocytosis is not required for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis.
Kohlhaas SL; Craxton A; Sun XM; Pinkoski MJ; Cohen GM
J Biol Chem; 2007 Apr; 282(17):12831-41. PubMed ID: 17327223
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of c-FLIP-short in response to TRAIL promotes survival of NSCLC cells, which could be suppressed by inhibition of Ca2+/calmodulin signaling.
Kaminskyy VO; Surova OV; Piskunova T; Zborovskaya IB; Tchevkina EM; Andera L; Zhivotovsky B
Cell Death Dis; 2013 Mar; 4(3):e522. PubMed ID: 23470529
[TBL] [Abstract][Full Text] [Related]
9. MAPK p38 and JNK have opposing activities on TRAIL-induced apoptosis activation in NSCLC H460 cells that involves RIP1 and caspase-8 and is mediated by Mcl-1.
Azijli K; Yuvaraj S; van Roosmalen I; Flach K; Giovannetti E; Peters GJ; de Jong S; Kruyt FA
Apoptosis; 2013 Jul; 18(7):851-60. PubMed ID: 23456625
[TBL] [Abstract][Full Text] [Related]
10. Estrogen receptor α promotes lung cancer cell invasion via increase of and cross-talk with infiltrated macrophages through the CCL2/CCR2/MMP9 and CXCL12/CXCR4 signaling pathways.
He M; Yu W; Chang C; Miyamoto H; Liu X; Jiang K; Yeh S
Mol Oncol; 2020 Aug; 14(8):1779-1799. PubMed ID: 32356397
[TBL] [Abstract][Full Text] [Related]
11. TRAIL Receptors Serve as Stress-Associated Molecular Patterns to Promote ER-Stress-Induced Inflammation.
Sullivan GP; O'Connor H; Henry CM; Davidovich P; Clancy DM; Albert ML; Cullen SP; Martin SJ
Dev Cell; 2020 Mar; 52(6):714-730.e5. PubMed ID: 32109381
[TBL] [Abstract][Full Text] [Related]
12. Quinacrine induces apoptosis in cancer cells by forming a functional bridge between TRAIL-DR5 complex and modulating the mitochondrial intrinsic cascade.
Das S; Tripathi N; Preet R; Siddharth S; Nayak A; Bharatam PV; Kundu CN
Oncotarget; 2017 Jan; 8(1):248-267. PubMed ID: 27542249
[TBL] [Abstract][Full Text] [Related]
13. DDIAS suppresses TRAIL-mediated apoptosis by inhibiting DISC formation and destabilizing caspase-8 in cancer cells.
Im JY; Kim BK; Lee JY; Park SH; Ban HS; Jung KE; Won M
Oncogene; 2018 Mar; 37(9):1251-1262. PubMed ID: 29242605
[TBL] [Abstract][Full Text] [Related]
14. ABT-737 induces expression of the death receptor 5 and sensitizes human cancer cells to TRAIL-induced apoptosis.
Song JH; Kandasamy K; Kraft AS
J Biol Chem; 2008 Sep; 283(36):25003-13. PubMed ID: 18599488
[TBL] [Abstract][Full Text] [Related]
15. Cell-surface galectin-3 confers resistance to TRAIL by impeding trafficking of death receptors in metastatic colon adenocarcinoma cells.
Mazurek N; Byrd JC; Sun Y; Hafley M; Ramirez K; Burks J; Bresalier RS
Cell Death Differ; 2012 Mar; 19(3):523-33. PubMed ID: 21941373
[TBL] [Abstract][Full Text] [Related]
16. Dual role of DR5 in death and survival signaling leads to TRAIL resistance in cancer cells.
Shlyakhtina Y; Pavet V; Gronemeyer H
Cell Death Dis; 2017 Aug; 8(8):e3025. PubMed ID: 29048428
[TBL] [Abstract][Full Text] [Related]
17. TRAIL-induced survival and proliferation of SCLC cells is mediated by ERK and dependent on TRAIL-R2/DR5 expression in the absence of caspase-8.
Belyanskaya LL; Ziogas A; Hopkins-Donaldson S; Kurtz S; Simon HU; Stahel R; Zangemeister-Wittke U
Lung Cancer; 2008 Jun; 60(3):355-65. PubMed ID: 18093694
[TBL] [Abstract][Full Text] [Related]
18. The caspase 9 inhibitor Z-LEHD-FMK protects human liver cells while permitting death of cancer cells exposed to tumor necrosis factor-related apoptosis-inducing ligand.
Ozoren N; Kim K; Burns TF; Dicker DT; Moscioni AD; El-Deiry WS
Cancer Res; 2000 Nov; 60(22):6259-65. PubMed ID: 11103780
[TBL] [Abstract][Full Text] [Related]
19. Galbanic acid potentiates TRAIL induced apoptosis in resistant non-small cell lung cancer cells via inhibition of MDR1 and activation of caspases and DR5.
Kim YH; Shin EA; Jung JH; Park JE; Koo J; Koo JI; Shim BS; Kim SH
Eur J Pharmacol; 2019 Mar; 847():91-96. PubMed ID: 30689998
[TBL] [Abstract][Full Text] [Related]
20. Procaspase 8 overexpression in non-small-cell lung cancer promotes apoptosis induced by FLIP silencing.
Wilson TR; Redmond KM; McLaughlin KM; Crawford N; Gately K; O'Byrne K; Le-Clorrenec C; Holohan C; Fennell DA; Johnston PG; Longley DB
Cell Death Differ; 2009 Oct; 16(10):1352-61. PubMed ID: 19543235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
